These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18406747)

  • 1. The inhibin/activin family and ovarian cancer.
    Burger HG; Fuller PJ
    Trends Endocrinol Metab; 1996 Aug; 7(6):197-202. PubMed ID: 18406747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG
    J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin subunit gene expression in ovarian cancer.
    Fuller PJ; Chu S; Jobling T; Mamers P; Healy DL; Burger HG
    Gynecol Oncol; 1999 May; 73(2):273-9. PubMed ID: 10329046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
    Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
    Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin forms in serum from postmenopausal women with ovarian cancers.
    Robertson DM; Cahir N; Burger HG; Mamers P; Groome N
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):381-6. PubMed ID: 10435065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibins/activins as diagnostic markers for ovarian cancer.
    Robertson DM; Stephenson T; Pruysers E; Burger HG; McCloud P; Tsigos A; Groome N; Mamers P; McNeilage J; Jobling T; Healy D
    Mol Cell Endocrinol; 2002 May; 191(1):97-103. PubMed ID: 12044923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma.
    Menon U; Riley SC; Thomas J; Bose C; Dawnay A; Evans LW; Groome NP; Jacobs IJ
    BJOG; 2000 Sep; 107(9):1069-74. PubMed ID: 11002947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours.
    Burger HG; Robertson DM; Cahir N; Mamers P; Healy DL; Jobling T; Groome N
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):413-8. PubMed ID: 8706307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.
    Gurusinghe CJ; Healy DL; Jobling T; Mamers P; Burger HG
    Gynecol Oncol; 1995 Apr; 57(1):27-32. PubMed ID: 7705698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits.
    Cobellis L; Cataldi P; Reis FM; De Palo G; Raspagliesi F; Pilotti S; Arcuri F; Petraglia F
    Eur J Endocrinol; 2001 Dec; 145(6):779-84. PubMed ID: 11720904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
    Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
    N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total inhibin is a potential serum marker for epithelial ovarian cancer.
    Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors.
    Petraglia F; Luisi S; Pautier P; Sabourin JC; Rey R; Lhomme C; Bidart JM
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1029-32. PubMed ID: 9506769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor stroma as the main source of inhibin production in ovarian epithelial tumors.
    Zheng W; Lu JJ; Luo F; Hsieh J; Wang CY; Zhang C; Chang L; Cho MM; Stanczyk FZ
    Am J Reprod Immunol; 2000 Aug; 44(2):104-13. PubMed ID: 10994638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibins and ovarian cancer.
    Burger HG; Fuller PJ; Chu S; Mamers P; Drummond A; Susil B; Neva P; Robertson DM
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):145-8. PubMed ID: 11451584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of inhibin A and activin A subunit gene loci in epithelial ovarian cancer.
    Depasquale S; Lambert-Messerlian G; Quddus MR; Campbell I; Steinhoff M; Gajewski W; Granai C; Tantravahi U
    Int J Gynecol Cancer; 2002; 12(5):443-7. PubMed ID: 12366660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of inhibin as a biomarker for ovarian cancer.
    Robertson DM; Oehler MK
    Womens Health (Lond); 2005 Jul; 1(1):51-7. PubMed ID: 19803946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of total inhibin in diagnosis and monitoring of ovarian cancer in postmenopausal women].
    Markova D; Milchev N; Batashki I; Uchikov A
    Akush Ginekol (Sofiia); 2008; 47(1):16-9. PubMed ID: 18642569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.